359 related articles for article (PubMed ID: 12204600)
1. Prospects for cationic polymers in gene and oligonucleotide therapy against cancer.
Merdan T; Kopecek J; Kissel T
Adv Drug Deliv Rev; 2002 Sep; 54(5):715-58. PubMed ID: 12204600
[TBL] [Abstract][Full Text] [Related]
2. Non-viral vectors in cancer gene therapy: principles and progress.
Schatzlein AG
Anticancer Drugs; 2001 Apr; 12(4):275-304. PubMed ID: 11335785
[TBL] [Abstract][Full Text] [Related]
3. Peptide vectors for the nonviral delivery of nucleic acids.
Hoyer J; Neundorf I
Acc Chem Res; 2012 Jul; 45(7):1048-56. PubMed ID: 22455499
[TBL] [Abstract][Full Text] [Related]
4. Delivery of antisense oligonucleotides using poly(alkylene oxide)-poly(propylacrylic acid) graft copolymers in conjunction with cationic liposomes.
Peddada LY; Garbuzenko OB; Devore DI; Minko T; Roth CM
J Control Release; 2014 Nov; 194():103-12. PubMed ID: 25192941
[TBL] [Abstract][Full Text] [Related]
5. Antisense oligonucleotides in cancer.
Castanotto D; Stein CA
Curr Opin Oncol; 2014 Nov; 26(6):584-9. PubMed ID: 25188471
[TBL] [Abstract][Full Text] [Related]
6. Aerosol gene delivery using viral vectors and cationic carriers for in vivo lung cancer therapy.
Hong SH; Park SJ; Lee S; Cho CS; Cho MH
Expert Opin Drug Deliv; 2015 Jun; 12(6):977-91. PubMed ID: 25423167
[TBL] [Abstract][Full Text] [Related]
7. Cationic polymer based nanocarriers for delivery of therapeutic nucleic acids.
Nimesh S; Gupta N; Chandra R
J Biomed Nanotechnol; 2011 Aug; 7(4):504-20. PubMed ID: 21870455
[TBL] [Abstract][Full Text] [Related]
8. Hyaluronan-based delivery of therapeutic oligonucleotides for treatment of human diseases.
Ossipov DA
Expert Opin Drug Deliv; 2019 Jun; 16(6):621-637. PubMed ID: 31072142
[TBL] [Abstract][Full Text] [Related]
9. Current status of delivery systems to improve target efficacy of oligonucleotides.
Shoji Y; Nakashima H
Curr Pharm Des; 2004; 10(7):785-96. PubMed ID: 15032703
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a new biocompatible poly(N-(morpholino ethyl methacrylate)-based copolymer for the delivery of ruthenium oligonucleotides, targeting HPV16 E6 oncogene.
Reschner A; Shim YH; Dubois P; Delvenne P; Evrard B; Marcélis L; Moucheron C; Kirsch-De Mesmaeker A; Defrancq E; Raes M; Piette J; Collard L; Piel G
J Biomed Nanotechnol; 2013 Aug; 9(8):1432-40. PubMed ID: 23926811
[TBL] [Abstract][Full Text] [Related]
11. Is there a future for cell-penetrating peptides in oligonucleotide delivery?
Lee SH; Castagner B; Leroux JC
Eur J Pharm Biopharm; 2013 Sep; 85(1):5-11. PubMed ID: 23958313
[TBL] [Abstract][Full Text] [Related]
12. Oligonucleotide delivery: a patent review (2010 - 2013).
Grijalvo S; Aviñó A; Eritja R
Expert Opin Ther Pat; 2014 Jul; 24(7):801-19. PubMed ID: 24798406
[TBL] [Abstract][Full Text] [Related]
13. Cationic lipids, phosphatidylethanolamine and the intracellular delivery of polymeric, nucleic acid-based drugs (review).
Hope MJ; Mui B; Ansell S; Ahkong QF
Mol Membr Biol; 1998; 15(1):1-14. PubMed ID: 9595549
[TBL] [Abstract][Full Text] [Related]
14. Novel antisense therapeutics delivery systems: In vitro and in vivo studies of liposomes targeted with anti-CD20 antibody.
Meissner JM; Toporkiewicz M; Czogalla A; Matusewicz L; Kuliczkowski K; Sikorski AF
J Control Release; 2015 Dec; 220(Pt A):515-528. PubMed ID: 26585505
[TBL] [Abstract][Full Text] [Related]
15. Oligonucleotide delivery to tumours using macromolecular carriers.
Dass CR
Biotechnol Appl Biochem; 2004 Oct; 40(Pt 2):113-22. PubMed ID: 15070400
[TBL] [Abstract][Full Text] [Related]
16. Cationic lipid vectors for plasmid DNA delivery.
Hirko A; Tang F; Hughes JA
Curr Med Chem; 2003 Jul; 10(14):1185-93. PubMed ID: 12678793
[TBL] [Abstract][Full Text] [Related]
17. Decationized polyplexes for gene delivery.
Novo L; Mastrobattista E; van Nostrum CF; Lammers T; Hennink WE
Expert Opin Drug Deliv; 2015 Apr; 12(4):507-12. PubMed ID: 25425332
[TBL] [Abstract][Full Text] [Related]
18. The delivery of antisense therapeutics.
Akhtar S; Hughes MD; Khan A; Bibby M; Hussain M; Nawaz Q; Double J; Sayyed P
Adv Drug Deliv Rev; 2000 Oct; 44(1):3-21. PubMed ID: 11035194
[TBL] [Abstract][Full Text] [Related]
19. Non-viral delivery of ribozymes for cancer gene therapy.
Kashani-Sabet M
Expert Opin Biol Ther; 2004 Nov; 4(11):1749-55. PubMed ID: 15500403
[TBL] [Abstract][Full Text] [Related]
20. In vivo characteristics of cationic liposomes as delivery vectors for gene therapy.
Audouy SA; de Leij LF; Hoekstra D; Molema G
Pharm Res; 2002 Nov; 19(11):1599-605. PubMed ID: 12458664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
